{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:08:51Z","timestamp":1792843731339,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00330-021-08411-w","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T19:03:47Z","timestamp":1642014227000},"page":"3480-3489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies"],"prefix":"10.1007","volume":"32","author":[{"given":"Amandine","family":"Laporte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kub\u00e9raka","family":"Mariampillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Pasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Donciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe A.","family":"Grenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Boussouar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"8411_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.chest.2016.04.007","volume":"150","author":"J Morisset","year":"2016","unstructured":"Morisset J, Johnson C, Rich E, Collard HR, Lee JS (2016) Management of myositis-related interstitial lung disease. Chest 150:1118\u20131128. https:\/\/doi.org\/10.1016\/j.chest.2016.04.007","journal-title":"Chest"},{"key":"8411_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1183\/16000617.00002015","volume":"24","author":"J-C Lega","year":"2015","unstructured":"Lega J-C, Reynaud Q, Belot A, Fabien N, Durieu I, Cottin V (2015) Idiopathic inflammatory myopathies and the lung. Eur Respir Rev 24:216\u2013238. https:\/\/doi.org\/10.1183\/16000617.00002015","journal-title":"Eur Respir Rev"},{"key":"8411_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JND-180308","volume":"5","author":"J Schmidt","year":"2018","unstructured":"Schmidt J (2018) Current classification and management of inflammatory myopathies. J Neuromuscul Dis 5:109\u2013129. https:\/\/doi.org\/10.3233\/JND-180308","journal-title":"J Neuromuscul Dis"},{"key":"8411_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347. https:\/\/doi.org\/10.1056\/NEJM197502132920706","journal-title":"N Engl J Med"},{"key":"8411_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","volume":"77","author":"C Marguerie","year":"1990","unstructured":"Marguerie C, Bunn CC, Beynon HL et al (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77:1019\u20131038. https:\/\/doi.org\/10.1093\/qjmed\/77.1.1019","journal-title":"Q J Med"},{"key":"8411_CR6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"RC Griggs","year":"1995","unstructured":"Griggs RC, Askanas V, DiMauro S et al (1995) Inclusion body myositis and myopathies. Ann Neurol 38:705\u2013713. https:\/\/doi.org\/10.1002\/ana.410380504","journal-title":"Ann Neurol"},{"key":"8411_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk JE, Amato AA, Lecky BR et al (2004) 119th ENMC International Workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14:337\u2013345. https:\/\/doi.org\/10.1016\/j.nmd.2004.02.006","journal-title":"Neuromuscul Disord"},{"key":"8411_CR8","doi-asserted-by":"publisher","first-page":"000507","DOI":"10.1136\/rmdopen-2017-000507","volume":"3","author":"M Bottai","year":"2017","unstructured":"Bottai M, Tj\u00e4rnlund A, Santoni G et al (2017) International Myositis Classification Criteria Project consortium, the Euromyositis Register and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland). EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open 3:000507. https:\/\/doi.org\/10.1136\/rmdopen-2017-000507","journal-title":"RMD Open"},{"key":"8411_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, McHugh N (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 280:8\u201323. https:\/\/doi.org\/10.1111\/joim.12451","journal-title":"J Intern Med"},{"key":"8411_CR10","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/WCO.0000000000000376","volume":"29","author":"O Benveniste","year":"2016","unstructured":"Benveniste O, Stenzel W, Allenbach Y (2016) Advances in serological diagnostics of inflammatory myopathies. Curr Opin Neurol 29:662\u2013673. https:\/\/doi.org\/10.1097\/WCO.0000000000000376","journal-title":"Curr Opin Neurol"},{"key":"8411_CR11","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai K, Granger B, Amelin D et al (2018) Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol 75:1528\u20131537. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2598","journal-title":"JAMA Neurol"},{"key":"8411_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1183\/09031936.03.00026703","volume":"22","author":"V Cottin","year":"2003","unstructured":"Cottin V, Thivolet-B\u00e9jui F, Reynaud-Gaubert M et al (2003) Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 22:245\u2013250. https:\/\/doi.org\/10.1183\/09031936.03.00026703","journal-title":"Eur Respir J"},{"key":"8411_CR13","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE et al (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164:1182\u20131185. https:\/\/doi.org\/10.1164\/ajrccm.164.7.2103110","journal-title":"Am J Respir Crit Care Med"},{"key":"8411_CR14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1164\/ajrccm\/141.3.727","volume":"141","author":"HD Tazelaar","year":"1990","unstructured":"Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV (1990) Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 141:727\u2013733. https:\/\/doi.org\/10.1164\/ajrccm\/141.3.727","journal-title":"Am Rev Respir Dis"},{"key":"8411_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.resinv.2016.09.006","volume":"55","author":"T Fujisawa","year":"2017","unstructured":"Fujisawa T, Hozumi H, Kono M et al (2017) Predictive factors for long-term outcome in polymyositis\/dermatomyositis-associated interstitial lung diseases. Respir Investig 55:130\u2013137. https:\/\/doi.org\/10.1016\/j.resinv.2016.09.006","journal-title":"Respir Investig"},{"key":"8411_CR16","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.rmed.2007.02.017","volume":"101","author":"WJ Huh","year":"2007","unstructured":"Huh WJ, Kim SD, Lee CK et al (2007) Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 101:1761\u20131769. https:\/\/doi.org\/10.1016\/j.rmed.2007.02.017","journal-title":"Respir Med"},{"key":"8411_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.23571","volume":"59","author":"M Fathi","year":"2008","unstructured":"Fathi M, Vikgren J, Boijsen M et al (2008) Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 59:677\u2013685. https:\/\/doi.org\/10.1002\/art.23571","journal-title":"Arthritis Rheum"},{"key":"8411_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0720-048X(03)00094-9","volume":"49","author":"O Bonnefoy","year":"2004","unstructured":"Bonnefoy O, Ferretti G, Calaque O et al (2004) Serial chest CT findings in interstitial lung disease associated with polymyositis\u2013dermatomyositis. Eur J Radiol 49:235\u2013244. https:\/\/doi.org\/10.1016\/S0720-048X(03)00094-9","journal-title":"Eur J Radiol"},{"key":"8411_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098824","volume":"9","author":"T Fujisawa","year":"2014","unstructured":"Fujisawa T, Hozumi H, Kono M et al (2014) Prognostic factors for myositis-associated interstitial lung disease. PLoS One 9:e98824. https:\/\/doi.org\/10.1371\/journal.pone.0098824","journal-title":"PLoS One"},{"key":"8411_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.chest.2020.01.033","volume":"158","author":"R Jablonski","year":"2020","unstructured":"Jablonski R, Bhorade S, Strek ME, Dematte J (2020) Recognition and management of myositis-associated rapidly progressive interstitial lung disease. Chest 158:252\u2013263. https:\/\/doi.org\/10.1016\/j.chest.2020.01.033","journal-title":"Chest"},{"key":"8411_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejrad.2007.05.017","volume":"66","author":"S Karadimitrakis","year":"2008","unstructured":"Karadimitrakis S, Plastiras SC, Zormpala, et al (2008) Chest CT findings in patients with inflammatory myopathy and Jo1 antibodies. Eur J Radiol 66:27\u201330. https:\/\/doi.org\/10.1016\/j.ejrad.2007.05.017","journal-title":"Eur J Radiol"},{"key":"8411_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society\/European Respiratory Society Statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST","journal-title":"Am J Respir Crit Care Med"},{"key":"8411_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell DM, Bankier AA, MacMahon H, Mcloud TC, M\u00fcller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697\u2013722. https:\/\/doi.org\/10.1148\/radiol.2462070712","journal-title":"Radiology"},{"key":"8411_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/BOR.0000000000000537","volume":"30","author":"JB Lilleker","year":"2018","unstructured":"Lilleker JB (2018) Advances in the early diagnosis and therapy of inclusion body myositis. Curr Opin Rheumatol 30:644\u2013649. https:\/\/doi.org\/10.1097\/BOR.0000000000000537","journal-title":"Curr Opin Rheumatol"},{"key":"8411_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semarthrit.2020.11.009","volume":"51","author":"KY Sun","year":"2021","unstructured":"Sun KY, Fan Y, Wang YX, Zhong YJ, Wang GF (2021) Prevalence of interstitial lung disease in polymyositis and dermatomyositis: a meta-analysis from 2000 to 2020. Semin Arthritis Rheum 51:175\u2013191. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.11.009","journal-title":"Semin Arthritis Rheum"},{"key":"8411_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EKL (2017) A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52:1\u201319. https:\/\/doi.org\/10.1007\/s12016-015-8510-y","journal-title":"Clin Rev Allergy Immunol"},{"key":"8411_CR27","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.rmed.2011.05.006","volume":"105","author":"K Tanizawa","year":"2011","unstructured":"Tanizawa K, Handa T, Nakashima R et al (2011) HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med 105:1380\u20131387. https:\/\/doi.org\/10.1016\/j.rmed.2011.05.006","journal-title":"Respir Med"},{"key":"8411_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","volume":"21","author":"H Hozumi","year":"2016","unstructured":"Hozumi H, Fujisawa T, Nakashima R et al (2016) Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease. Respir Med 21:91\u201399. https:\/\/doi.org\/10.1016\/j.rmed.2016.10.019","journal-title":"Respir Med"},{"key":"8411_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s40674-018-0110-6","volume":"5","author":"C Shappley","year":"2019","unstructured":"Shappley C, Paik JJ, Saketk OO (2019) Myositis-related interstitial lung disease: diagnostic with dermatomyositis. Curr Treatm Opt Rheumatol 5:56\u201383. https:\/\/doi.org\/10.1007\/s40674-018-0110-6","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"8411_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.resinv.2018.07.007","volume":"56","author":"S Sakamoto","year":"2018","unstructured":"Sakamoto S, Okamoto M, Kaieda S et al (2018) Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis. Respir Investig 56:464\u2013472. https:\/\/doi.org\/10.1016\/j.resinv.2018.07.007","journal-title":"Respir Investig"},{"key":"8411_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.resinv.2016.08.007","volume":"55","author":"N Yoshida","year":"2017","unstructured":"Yoshida N, Okamoto M, Kaieda S et al (2017) Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5-antibody with the therapeutic response of polymyositis\/dermatomyositis-associated interstitial lung disease. Respir Investig 55:24\u201332. https:\/\/doi.org\/10.1016\/j.resinv.2016.08.007","journal-title":"Respir Investig"},{"key":"8411_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.rmed.2013.01.014","volume":"107","author":"K Tanizawa","year":"2013","unstructured":"Tanizawa K, Handa T, Nakashima R et al (2013) The prognostic value of HRCT in myositis-associated interstitial lung disease. Respir Med 107:745\u2013752. https:\/\/doi.org\/10.1016\/j.rmed.2013.01.014","journal-title":"Respir Med"},{"key":"8411_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amjms.2017.07.013","volume":"355","author":"F Chen","year":"2018","unstructured":"Chen F, Li S, Wang T, Shi J, Wang G (2018) Clinical heterogeneity of interstitial lung disease in polymyositis and dermatomyositis patients with or without specific autoantibodies. Am J Med Sci 355:48\u201353. https:\/\/doi.org\/10.1016\/j.amjms.2017.07.013","journal-title":"Am J Med Sci"},{"key":"8411_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wanlong","year":"2021","unstructured":"Wanlong W, Li G, Yakai F et al (2021) Interstitial lung disease in anti-MDA5 positive dermatomyositis. Clin Rev Allergy Immunol 60:293\u2013304. https:\/\/doi.org\/10.1007\/s12016-020-08822-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"8411_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11926-013-0359-6","volume":"15","author":"PD Kiely","year":"2013","unstructured":"Kiely PD, Chua F (2013) Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis. Curr Rheumatol Rep 15:359. https:\/\/doi.org\/10.1007\/s11926-013-0359-6","journal-title":"Curr Rheumatol Rep"},{"key":"8411_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MCC.0000000000000373","volume":"23","author":"M Aublanc","year":"2017","unstructured":"Aublanc M, Perinel S, Gu\u00e9rin C (2017) Acute respiratory distress syndrome mimics: the role of lung biopsy. Curr Opin Crit Care 23:24\u201329. https:\/\/doi.org\/10.1097\/MCC.0000000000000373","journal-title":"Curr Opin Crit Care"},{"key":"8411_CR37","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1164\/rccm.201508-1632OC","volume":"193","author":"JP Hutchinson","year":"2016","unstructured":"Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB (2016) In hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011. Am J Respir Crit Care Med 193:1161\u20131167. https:\/\/doi.org\/10.1164\/rccm.201508-1632OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8411_CR38","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1007\/s00330-019-06152-5","volume":"29","author":"H Liu","year":"2019","unstructured":"Liu H, Xie S, Liang T, Sun H et al (2019) Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome. Eur Radiol 29:5349\u20135357. https:\/\/doi.org\/10.1007\/s00330-019-06152-5","journal-title":"Eur Radiol"},{"key":"8411_CR39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ejrad.2014.11.026","volume":"84","author":"M-P Debray","year":"2015","unstructured":"Debray M-P, Borie R, Revel M-P et al (2015) Interstitial lung disease in anti-synthetase syndrome: initial and follow-up CT findings. Eur J Radiol 84:516\u2013523. https:\/\/doi.org\/10.1016\/j.ejrad.2014.11.026","journal-title":"Eur J Radiol"},{"key":"8411_CR40","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/rheumatology\/keaa372","volume":"60","author":"S Li","year":"2021","unstructured":"Li S, Sun Y, Shao C et al (2021) Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases. Rheumatology (Oxford) 60:1195\u20131204. https:\/\/doi.org\/10.1093\/rheumatology\/keaa372","journal-title":"Rheumatology (Oxford)"},{"key":"8411_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1148\/radiology.212.2.r99au05567","volume":"212","author":"T Johkoh","year":"1999","unstructured":"Johkoh T, M\u00fcller NL, Pickford HA et al (1999) Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 212:567\u2013572. https:\/\/doi.org\/10.1148\/radiology.212.2.r99au05567","journal-title":"Radiology"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08411-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-021-08411-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08411-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T11:12:42Z","timestamp":1650885162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-021-08411-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["8411"],"URL":"https:\/\/doi.org\/10.1007\/s00330-021-08411-w","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Dr. Boussouar Samia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Dr. Mariampillai Kub\u00e9raka kindly provided statistical advice for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Some study subjects or cohorts have been previously reported in \u201cDevelopment of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies.\u201d <i>JAMA Neurology<\/i> 2018.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 retrospective\u2022 cross sectional study \/ diagnostic study \/ observational\u2022 performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}